TrialIntensive care medicine2016

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.

Mohd H Abdul-Aziz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.